Saiyed Atiq Raza Sells 2,776 Shares of Arteris, Inc. (NASDAQ:AIP) Stock

Arteris, Inc. (NASDAQ:AIP) Director Saiyed Atiq Raza sold 2,776 shares of the company’s stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $12.34, for a total value of $34,255.84. Following the completion of the sale, the director now owns 684,320 shares in the company, valued at $8,444,508.80. The trade was a 0.40 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Saiyed Atiq Raza also recently made the following trade(s):

• On Thursday, December 26th, Saiyed Atiq Raza sold 41,439 shares of Arteris stock. The shares were sold at an average price of $10.37, for a total transaction of $429,722.43.
• On Wednesday, December 18th, Saiyed Atiq Raza sold 12,166 shares of Arteris stock. The stock was sold at an average price of $10.07, for a total transaction of $122,511.62.
• On Wednesday, December 11th, Saiyed Atiq Raza sold 2,400 shares of Arteris stock. The shares were sold at an average price of $10.01, for a total value of $24,024.00.

Arteris Stock Performance

Shares of AIP stock opened at $11.25 on Friday. Arteris, Inc. has a 52-week low of $4.83 and a 52-week high of $12.64. The company has a 50-day simple moving average of $9.25 and a two-hundred day simple moving average of $8.15. The company has a market capitalization of $451.99 million, a price-to-earnings ratio of -11.72 and a beta of 1.17. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.16 and a current ratio of 1.16.

Institutional Trading of Arteris

A number of hedge funds have recently bought and sold shares of AIP. US Bancorp DE purchased a new stake in shares of Arteris during the 3rd quarter valued at $34,000. The Manufacturers Life Insurance Company purchased a new stake in Arteris during the second quarter worth about $86,000. Algert Global LLC bought a new stake in Arteris in the second quarter worth about $115,000. MetLife Investment Management LLC raised its position in Arteris by 129.1% in the third quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock worth $131,000 after acquiring an additional 9,551 shares during the period. Finally, Dynamic Technology Lab Private Ltd purchased a new position in Arteris in the third quarter valued at about $226,000. 64.36% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Separately, Rosenblatt Securities restated a “buy” rating and set a $15.00 price target on shares of Arteris in a research note on Wednesday, November 6th.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.